Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions
Journal of Evaluation in Clinical Practice · 2025-10 · 31 (7)
DOI: 10.1111/jep.70283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Evaluation in Clinical Practice, online erschienen am 30.09.2025. Verfasst von N N Ngcobo. Beteiligte Einrichtung: Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. Hauptthemen laut MEDLINE: Polypharmacy, Multimorbidity, Drug-Related Side Effects and Adverse Reactions, Medication Errors. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Medikationssicherheit
Abstract (Originalsprache)
Background
Pharmacological therapy in older persons is inherently complex due to the interplay of age‐related physiological changes, multimorbidity, and polypharmacy. These factors increase the vulnerability of elderly patients to drug interactions and adverse drug reactions.
Aim
This review aims to examine the mechanisms, causes, and consequences of drug interactions in older persons, and to highlight strategies to optimise pharmacological therapy in this population.
Methods
A narrative review of current literature was conducted, focusing on studies that address age‐related pharmacological changes, multimorbidity, polypharmacy, and drug–drug interactions in elderly patients.
Results
Findings from the literature indicate that drug interactions represent one of the most preventable medical errors in older persons' pharmacotherapy. The global scale of this problem highlights the need for increased awareness and collaborative approaches among healthcare providers.
Conclusion
Improving the quality of pharmacotherapy in older adults requires a concerted effort to prevent drug interactions, optimise prescribing practices, and ensure patient safety. Collaborative interventions can reduce adverse drug events and enhance therapeutic outcomes in elderly care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: N N Ngcobo
Zitieren
APA
Ngcobo, N. N. (2025). Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions. Journal of Evaluation in Clinical Practice, 31(7). https://doi.org/10.1111/jep.70283
Vancouver
Ngcobo NN. Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions. Journal of Evaluation in Clinical Practice. 2025;31(7). doi:10.1111/jep.70283
BibTeX
@article{Ngcobo2025,
author = {Ngcobo, N N},
title = {Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions},
journal = {Journal of Evaluation in Clinical Practice},
year = {2025},
volume = {31},
number = {7},
doi = {10.1111/jep.70283}
}
EUVIMED